THE EFFECT OF TAMSULOSIN 0.4 MG ADMINISTRATION TOWARDS ALTERATION OF PROSTATE SPECIFIC ANTIGEN (PSA) LEVELS IN BENIGN PROSTATIC HYPERPLASIA (BPH) PATIENTS IN PADANG CITY
##plugins.themes.bootstrap3.article.main##
##plugins.themes.bootstrap3.article.sidebar##
Abstract
Objective: This study aims to determine the effect of tamsulosin administration on alteration in PSA levels in BPH patients in Padang. Material & Methods: This study employed an analytical method with a prospective cohort design. The research was conducted at M. Djamil General Hospital, BMC Hospital, Hermina Hospital, and Semen Padang Hospital in August - December 2022. Sampling was carried out by consecutive sampling. Results: At the end of the study, there were 23 patients with BPH. The mean age was 67.5 ± 7.7, which most of them having good education. Patients were mostly self-employed. The highest IPSS score is the severe stage. The PSA levels before and after tamsulosin administration were 1.7 ± 0.9 ng/ml and 1.6 ± 0.8 ng/ml, respectively. Bivariate analysis showed that tamsulosin administration affects PSA levels in benign prostatic hyperplasia patients in Padang. Conclusion: There is an effect of tamsulosin administration on PSA levels. Keywords: Benign prostatic hyperplasia, tamsulosin, prostate-specific antigen.
##plugins.themes.bootstrap3.article.details##
Benign prostatic hyperplasia, Tamsulsosin, Prostate-specific antigen
Michael Ng A, Baradhi KM. Benign Prostatic Hyperplasia Continuing Education Activity. NCBI Bookshelf. 2022.
Yeboah Ed. Prevalence Of Benign Prostatic Hyperplasia And Prostate Cancer In Africans And Africans In The Diaspora. J West Afr Coll Surg. 2016; 6(4): 1–30.
Madersbacher S, Sampson N, Culig Z. Pathophysiology of Benign Prostatic Hyperplasia and Benign Prostatic Enlargement: A Mini-Review. Vol. 65, Gerontology. S. Karger AG; 2019. p. 458–64.
Tjahjodjati, Soebadi DM, Umbas R, et al. Panduan Pentalaksanaan Klinis Pembesaran Prostat Jinak. Bandung: Ikatan Ahli Urologi Indonesia; 2021.
Hanai T, Matsumoto S, Shouji S, Usui Y, Tang XY, Kato Y, et al. Changes in PSA due to administration of α1-adrenergic receptor blockers in patients with mildly elevated prostate-specific antigen (PSA): comparison between benign prostatic hyperplasia/lower urinary tract disease and prostate cancer. Bulletin of Urology. 2009; 55: 187–91.
Minutoli L, Rinaldi M, Marini H, Irrera N, Crea G, Lorenzini C, et al. Apoptotic pathways linked to endocrine system as potential therapeutic targets for benign prostatic hyperplasia. Vol. 17, International Journal of Molecular Sciences. MDPI AG; 2016.
Prasetyo ZA, Budaya TN, Daryanto B. Characteristics of Benign Prostatic Hyperplasia (BPH) Patients Undergoing Transurethral Resection of the Prostate (TURP). Jurnal Kedokteran Brawijaya. 2021 Aug 31; 31(4): 4.
Baradhi NM. Benign Prostatic Hyperplasia. Statpearls Publishing. 2022.
Lim K bin. Epidemiology of clinical benign prostatic hyperplasia. Vol. 4, Asian Journal of Urology. Editorial Office of Asian Journal of Urology; 2017. p. 148–51.
Liu TT, Thomas S, Mclean DT, Roldan-Alzate A, Hernando D, Ricke EA, et al. Prostate enlargement and altered urinary function are part of the aging process. Aging. 2019; 11(9): 2653–60.
Sarauw A, Nompo R, Arvia A. Pengaruh pendidikan kesehatan tentang penyakit Benigna Prostate Hyperplasia (BPH) terhadap pengetahuan pasien di Ruang Bedah Pria RSUD Jayapura. Sentani Nursing Journal. 2021 Apr 15; 3(1): 1–7.
Lestari LL. Hubungan usia dan pekerjaan dengan kejadian BPH di Poli Bedah dan ruang rawat inap bedah pria RSUD Achmad Mochtar Bukittinggi tahun 2014. [Bukittinggi]: Sekolah Tinggi Ilmu Kesehatan Perintis; 2014.
Maharany RA. Hubungan pekerjaan dengan kejadian Benigna Prostat Hiperplasia (BPH) di Rumah Sakit Pertamina Bintang Amin Bandar Lampung tahun 2020-2021 [Skripsi]. [Lampung]: Universitas Malahayati; 2022.
Tubaro A, de Nunzio C, Mariani S, Trucchi A, Miano R, Vicentini C, et al. Reduction of prostate-specific antigen after tamsulosin treatment in patients with elevated prostate-specific antigen and lower urinary tract symptoms associated with low incidence of prostate cancer at biopsy. Urology. 2010 Aug; 76(2): 436–41.
Kyprianou N, Jacobs SC. Induction of Apoptosis in the Prostate by 1-Adrenoceptor Antagonists: A Novel Effect of "Old" Drugs. Curr Urol Rep. 2000; 1: 89–96.
Server Pastor G, Nicolás Torralba JA, Bañón Pérez V, Valdelvira Nadal P, Rigabert Montiel M, López Cubillana P, et al. Is PSA density able to predict the response to alpha-blockers in benign prostatic hyperplasia? Actas Urol Esp. 2001; 25(2): 115–8.